Home/Filings/4/0000950170-24-104038
4//SEC Filing

Mano Michael 4

Accession 0000950170-24-104038

CIK 0001503802other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:28 PM ET

Size

4.9 KB

Accession

0000950170-24-104038

Insider Transaction Report

Form 4
Period: 2024-09-04
Mano Michael
SVP, General Counsel&Secretary
Transactions
  • Sale

    Common Stock

    2024-09-04$0.72/sh3,971$2,866273,881 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.

Documents

1 file

Issuer

Karyopharm Therapeutics Inc.

CIK 0001503802

Entity typeother

Related Parties

1
  • filerCIK 0001837741

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:28 PM ET
Size
4.9 KB